Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2015 1
2016 1
2017 1
2020 2
2021 3
2022 1
2023 2
2024 0

Text availability

Article attribute

Article type

Publication date

Search Results

8 results

Results by year

Filters applied: . Clear all
Page 1
Did you mean reiken s (100 results)?
Fixed drug eruption secondary to adalimumab.
Bhadresha S, Hughes AJ, McMahon L, Reeken S, Natkunarajah N. Bhadresha S, et al. Among authors: reeken s. Clin Exp Dermatol. 2021 Mar;46(2):366-368. doi: 10.1111/ced.14400. Epub 2020 Aug 30. Clin Exp Dermatol. 2021. PMID: 33448464 No abstract available.
Melanoma: summary of NICE guidance.
Macbeth F, Newton-Bishop J, O'Connell S, Hawkins JE; Guideline Development Group. Macbeth F, et al. BMJ. 2015 Jul 29;351:h3708. doi: 10.1136/bmj.h3708. BMJ. 2015. PMID: 26223435 Free article. No abstract available.
Differences in Clinical Features and Comorbid Burden between HLA-C∗06:02 Carrier Groups in >9,000 People with Psoriasis.
Douroudis K, Ramessur R, Barbosa IA, Baudry D, Duckworth M, Angit C, Capon F, Chung R, Curtis CJ, Di Meglio P, Goulding JMR, Griffiths CEM, Lee SH, Mahil SK, Parslew R, Reynolds NJ, Shipman AR, Warren RB, Yiu ZZN, Simpson MA, Barker JN, Dand N, Smith CH; BADBIR; BSTOP Study Groups. Douroudis K, et al. J Invest Dermatol. 2022 Jun;142(6):1617-1628.e10. doi: 10.1016/j.jid.2021.08.446. Epub 2021 Nov 10. J Invest Dermatol. 2022. PMID: 34767815 Free article.
Factors associated with adverse COVID-19 outcomes in patients with psoriasis-insights from a global registry-based study.
Mahil SK, Dand N, Mason KJ, Yiu ZZN, Tsakok T, Meynell F, Coker B, McAteer H, Moorhead L, Mackenzie T, Rossi MT, Rivera R, Mahe E, Carugno A, Magnano M, Rech G, Balogh EA, Feldman SR, De La Cruz C, Choon SE, Naldi L, Lambert J, Spuls P, Jullien D, Bachelez H, McMahon DE, Freeman EE, Gisondi P, Puig L, Warren RB, Di Meglio P, Langan SM, Capon F, Griffiths CEM, Barker JN, Smith CH; PsoProtect study group. Mahil SK, et al. J Allergy Clin Immunol. 2021 Jan;147(1):60-71. doi: 10.1016/j.jaci.2020.10.007. Epub 2020 Oct 16. J Allergy Clin Immunol. 2021. PMID: 33075408 Free PMC article. Clinical Trial.
Clearer labelling of ingredients in medicines is required.
Krishna SK, Ganatra B, Reeken S, Natkunarajah J. Krishna SK, et al. Among authors: reeken s. Clin Exp Dermatol. 2017 Jun;42(4):428. doi: 10.1111/ced.13067. Epub 2017 Feb 20. Clin Exp Dermatol. 2017. PMID: 28218422 No abstract available.